{"gene":"SLC16A7","run_date":"2026-06-10T07:46:32","timeline":{"discoveries":[{"year":1995,"finding":"MCT2 (SLC16A7) transports pyruvate and lactate in a proton-coupled manner; it is sensitive to phloretin and alpha-cyano-4-hydroxycinnamate but insensitive to organomercurial thiol reagents (e.g., p-chloromercuribenzoic acid), distinguishing it from MCT1. Functional activity was demonstrated by expression in Sf9 insect cells using recombinant baculovirus vectors.","method":"Heterologous expression in Sf9 insect cells (baculovirus), transport assays, pharmacological inhibition, immunoblotting/immunofluorescence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct reconstitution of transport activity in heterologous expression system with pharmacological characterization; foundational study replicated extensively","pmids":["7829520"],"is_preprint":false},{"year":1999,"finding":"MCT2 is a high-affinity H+/monocarboxylate transporter with Km ~0.74 mM for lactate at pH 7.0 (approximately 10-fold higher affinity than MCT1). Substrates include lactate, pyruvate, β-hydroxybutyrate, acetoacetate, and branched-chain keto acids. Transport is driven by the H+ gradient and is inhibited by alpha-cyano-4-hydroxycinnamate, anion-channel inhibitors, and flavonoids.","method":"Heterologous expression in Xenopus laevis oocytes, radiolabeled transport assays, inhibition kinetics","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — detailed kinetic characterization in Xenopus oocyte expression system with multiple substrates and inhibitors; replicated across labs","pmids":["10417314"],"is_preprint":false},{"year":1998,"finding":"Human MCT2 (SLC16A7) is a high-affinity pyruvate transporter with an apparent Km of ~25 µM for pyruvate, functioning as a H+/monocarboxylate cotransporter. The gene maps to chromosome 12q13.","method":"cDNA cloning, heterologous expression, kinetic transport assays, fluorescence in situ hybridization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct transport kinetics in heterologous expression system; independently consistent with other species characterizations","pmids":["9786900"],"is_preprint":false},{"year":2005,"finding":"MCT2 associates with the ancillary protein embigin (gp70) rather than basigin (CD147) for plasma membrane expression, in contrast to MCT1 and MCT4 which associate with basigin. This interaction was confirmed by co-immunoprecipitation and FRET between CFP/YFP-tagged MCT2 and gp70. The MCT2-embigin association explains the insensitivity of MCT2 to pCMBS inhibition, because pCMBS targets the disulfide bridge in the Ig-like C2 domain of CD147.","method":"Co-immunoprecipitation, FRET (CFP/YFP-tagged proteins), site-directed mutagenesis of CD147, cell-impermeant organomercurial inhibitor assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reciprocal co-IP plus FRET plus mutagenesis in single study; mechanistically explains pharmacological phenotype","pmids":["15917240"],"is_preprint":false},{"year":2010,"finding":"AR-C155858 is a potent inhibitor of MCT2 (and MCT1) that binds to an intracellular site involving transmembrane helices 7–10. Inhibition is time-dependent and the compound is active when microinjected, confirming intracellular binding. MCT4 is not inhibited. Chimeric transporter experiments localized the binding site to the C-terminal half of MCT1 (and by extension MCT2).","method":"Xenopus oocyte expression, inhibitor titrations, microinjection, chimeric MCT1/MCT4 constructs, Km determination","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in heterologous system with chimeric constructs and microinjection to map binding site; replicated with multiple constructs","pmids":["19929853"],"is_preprint":false},{"year":2010,"finding":"The ancillary protein associated with MCT2 modulates its sensitivity to AR-C155858: MCT2 expressed with endogenous Xenopus basigin is potently inhibited by AR-C155858, whereas MCT2 co-expressed with exogenous embigin is insensitive to AR-C155858. Embigin modulates MCT2 inhibitor sensitivity through interactions with the intracellular C-terminus and TMs 3 and 6. Lactate Km is determined primarily by the TM domains (TM7–12) of MCT2 and not by the associated ancillary protein.","method":"Xenopus oocyte expression, co-expression of embigin/basigin, chimeric and truncation constructs, inhibitor titrations, RT-PCR","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple chimeric constructs and ancillary protein swap in reconstituted oocyte system; single lab but multiple orthogonal methods","pmids":["20695846"],"is_preprint":false},{"year":2011,"finding":"Extracellular membrane-bound carbonic anhydrase IV (CAIV), but not cytosolic CAII, enhances transport activity of MCT2. CAIV augmentation of MCT2 is independent of CAIV catalytic activity (shown by ethoxyzolamide treatment and catalytically inactive CAIV-V165Y mutant) and does not require its intramolecular H+-shuttle residue His-88. Enhancement only occurs when MCT2 is co-expressed with its ancillary protein embigin (gp70).","method":"Xenopus oocyte co-expression, pharmacological inhibition, site-directed mutagenesis of CAIV, electrophysiological transport assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in Xenopus oocytes with mutagenesis and pharmacological controls; single lab, multiple orthogonal approaches","pmids":["21680735"],"is_preprint":false},{"year":2013,"finding":"Neuroplastins (np65 and np55), Ig superfamily adhesion molecules, act as ancillary proteins for MCT2, enabling its plasma membrane expression and lactate transport activity. Demonstrated by co-transfection in COS-7 cells, knockdown of endogenous Xenopus neuroplastin reducing MCT2 surface expression and transport, and co-localization of MCT2 and neuroplastins in rat cerebellum (parasagittal zebrin II-negative stripes).","method":"Co-transfection in COS-7 cells, Xenopus oocyte antisense RNA knockdown, immunocytochemistry, lactate transport assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (co-transfection, KD in oocytes, immunocytochemistry, transport assay); single lab","pmids":["24260123"],"is_preprint":false},{"year":2001,"finding":"MCT2 is concentrated at postsynaptic densities of parallel fiber–Purkinje cell synapses in cerebellum, co-localizing with delta2 glutamate receptors, as shown by immunogold electron microscopy. This identifies MCT2 as a novel postsynaptic density protein.","method":"Confocal immunofluorescence microscopy, double-labeling immunogold electron microscopy","journal":"Experimental brain research","confidence":"High","confidence_rationale":"Tier 2 / Strong — immunogold EM with quantitative double-labeling provides subcellular resolution; replicated in subsequent studies","pmids":["11291733"],"is_preprint":false},{"year":2005,"finding":"MCT2 is selectively localized at postsynaptic densities of asymmetric (glutamatergic) synapses in hippocampal CA1 and CA3 and cerebellar parallel fiber–Purkinje cell synapses. MCT2 co-distributes quantitatively with AMPA receptor GluR2/3 subunits within postsynaptic densities. A significant intracellular vesicular pool of MCT2 exists within postsynaptic spines, suggesting endo/exocytotic trafficking analogous to AMPA receptors.","method":"Post-embedding electron microscopic immunocytochemistry, quantitative double-labeling immunogold","journal":"Cerebral cortex","confidence":"High","confidence_rationale":"Tier 2 / Strong — quantitative immunogold EM with double labeling at defined synapse types; replicated across brain regions and species","pmids":["15749979"],"is_preprint":false},{"year":2009,"finding":"MCT2 co-immunoprecipitates with AMPA receptor GluR2/3 subunits and the GluR2/3-interacting protein PICK1 (C-kinase-interacting protein 1) in neurons, indicating a close physical interaction within dendritic spines. MCT2 and GluR2/3 undergo parallel membrane trafficking: AMPA or insulin stimulation causes intracellular accumulation of both, while TNF-α and glycine/glutamate increase their cell-surface expression. Surface translocation of MCT2 is associated with enhanced neuronal lactate uptake.","method":"Co-immunoprecipitation, immunofluorescence co-localization, cell-surface biotinylation, Western blot on membrane/cytoplasm fractions, fluorescent lactate flux assay","journal":"The European journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP plus parallel trafficking experiments with functional (lactate flux) validation; single lab, multiple orthogonal methods","pmids":["19453627"],"is_preprint":false},{"year":2009,"finding":"MCT2 protein expression in cultured cortical neurons is upregulated by insulin and IGF-1 through a translational (not transcriptional) mechanism requiring the PI3K–Akt–mTOR–S6K pathway. mTOR inhibitor rapamycin and PI3K inhibitor LY294002 almost completely blocked MCT2 protein upregulation, whereas MEK inhibitor PD98059 had no effect. The increase in MCT2 protein occurred in an intracellular pool without change at the cell surface.","method":"Western blot, qRT-PCR (no mRNA change), pharmacological pathway inhibitors, immunocytochemistry for subcellular localization","journal":"The European journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple signaling inhibitors used to map pathway; single lab; no genetic rescue to confirm pathway specificity","pmids":["18093179"],"is_preprint":false},{"year":2007,"finding":"Noradrenaline (NA) increases neuronal MCT2 protein expression via translational activation through the PI3K/Akt and mTOR/S6K pathway. LY294002 and rapamycin almost completely blocked NA-induced MCT2 upregulation, whereas MEK and p38 MAPK inhibitors had smaller effects. NA did not significantly alter MCT2 mRNA levels, confirming post-transcriptional regulation.","method":"Western blot, qRT-PCR, pharmacological inhibitors (LY294002, rapamycin, PD98059, SB202190), phosphorylation analyses","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway dissected with multiple selective inhibitors and mRNA/protein dissociation; single lab","pmids":["17394554"],"is_preprint":false},{"year":2009,"finding":"MCT2 co-immunoprecipitates with AQP9 (aquaglyceroporin) from hippocampal neuron homogenates, and both proteins co-localize in mitochondria of hippocampal neurons. Glutamate exposure enhances protein (but not mRNA) expression of both MCT2 and AQP9 in these neurons.","method":"Co-immunoprecipitation, immunofluorescence co-localization, Western blot, qRT-PCR","journal":"Frontiers in neuroscience","confidence":"Medium","confidence_rationale":"Tier 2–3 / Weak — co-IP and co-localization in single lab; mitochondrial localization inferred from co-localization, not fractionation validation","pmids":["25161606"],"is_preprint":false},{"year":2012,"finding":"In murine spermatozoa, basigin (CD147) co-localizes and co-immunoprecipitates with both MCT1 and MCT2, whereas embigin interaction was not detectable. This differs from somatic cells where MCT2 preferentially associates with embigin. MCT-mediated L-lactate transport (measured as pHi decrease) in sperm was blocked by alpha-cyano-4-OH cinnamate.","method":"Co-immunoprecipitation, immunofluorescence co-localization, intracellular pH measurement with fluorescent dye, ATP assay","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP with functional transport assay; single lab; cell-type-specific ancillary protein interaction","pmids":["21792931"],"is_preprint":false},{"year":2018,"finding":"MCT2 mediates cellular uptake of methyloxalylglycine (MOG), the hydrolysis product of DMOG. MCT2-facilitated entry of MOG into cells leads to sufficiently high intracellular concentrations of NOG to inhibit glutamate dehydrogenase and other glutamine metabolism enzymes, suppress mitochondrial respiration, decrease TCA-cycle flux from glutamine, and reduce ATP production, causing cytotoxicity in an MCT2-dependent manner.","method":"LC-MS metabolomics, MCT2 KD/KO, transport assays, mitochondrial respiration assays, cell viability assays","journal":"Nature chemical biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — transport mechanism linked to metabolic outcome via multiple orthogonal methods including metabolomics and genetic loss-of-function; single lab","pmids":["30297875"],"is_preprint":false},{"year":2022,"finding":"MOG analogues that maintain MCT2-dependent cell entry but do not inhibit glutaminolysis or cause cytotoxicity were identified, functionally mapping the MCT2 pharmacophore. These compounds can still inhibit PHDs, allowing uncoupling of glutaminolysis from PHD activity and demonstrating that MCT2 dictates the mode of action of NOG by controlling its intracellular concentration.","method":"Structure-activity relationship with MOG analogues, cell viability assays, metabolic flux assays, MCT2-expressing cell lines","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacophore mapping with multiple analogues and functional readouts; single lab","pmids":["36028752"],"is_preprint":false},{"year":2022,"finding":"Notch/RBP-J signaling represses MCT2 transcription via its downstream effector Hes1, reducing intracellular lactate levels in myeloid cells. Reduced MCT2-mediated lactate import blunts granulocytic MDSC differentiation and promotes TAM maturation. Lactate (transported via MCT2) was identified to interact with and stabilize c-Jun protein against FBW7 ubiquitin-ligase-mediated degradation, using LC-MS and CRISPR-Cas9 gene disruption.","method":"Chromatin immunoprecipitation (Hes1 at MCT2 locus), LC-MS (lactate-c-Jun interaction), CRISPR-Cas9 KO, flow cytometry, Western blot","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods including ChIP, LC-MS, and CRISPR in single lab; pathway placement with defined molecular mechanism","pmids":["35263597"],"is_preprint":false},{"year":2009,"finding":"MCT2 regulation of GluR2 AMPA receptor subcellular distribution was demonstrated: co-expression of MCT2 with GluR2-Venus in Neuro2A cells and cortical neurons caused GluR2 to redistribute into perinuclear and dendritic clusters following MCT2 distribution. MCT2 co-expression reduced both cell-surface and total GluR2 protein levels. MCT2 partially co-localized with Rab8 in dendrites, suggesting involvement in AMPA receptor membrane trafficking.","method":"Fluorescence microscopy with mStrawberry-MCT2 and Venus-GluR2 co-transfection, cell-surface biotinylation, Western blot","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct visualization of MCT2 influence on GluR2 trafficking with multiple readouts; single lab","pmids":["19457092"],"is_preprint":false},{"year":2017,"finding":"Neuronal MCT2 knockdown (~25%) in rat somatosensory cortex using lentiviral shRNA abrogated the activity-dependent increase in lactate content observed during whisker stimulation (measured by HRMAS 1H-NMR and in vivo 1H-NMR). MCT2 KD also attenuated TCA cycle velocity increase upon activation and abolished the BOLD fMRI response to whisker stimulation. 13C-labeling confirmed that elevated lactate during activation originates from newly synthesized glucose-derived lactate.","method":"Lentiviral shRNA KD, HRMAS 1H-NMR spectroscopy, 13C-NMR with [1-13C]glucose infusion, in vivo 1H-NMR, BOLD fMRI","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo genetic KD with multiple independent readouts (NMR, 13C-labeling, fMRI); single lab, orthogonal methods","pmids":["28388627"],"is_preprint":false},{"year":2015,"finding":"MCT2 localizes predominantly to peroxisomes in prostate cancer (PCa) cells, interacting with the peroxisomal membrane protein Pex19 to exploit the peroxisomal import machinery. This peroxisomal localization correlates with increased peroxisomal β-oxidation activity and is associated with malignant transformation.","method":"Immunofluorescence co-localization with peroxisomal markers, co-immunoprecipitation with Pex19, Western blot, immunohistochemistry","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — co-IP of MCT2-Pex19 interaction with co-localization and functional correlation; single lab","pmids":["25639644"],"is_preprint":false},{"year":2020,"finding":"Peroxisomal localization of MCT2 is required for PCa cell proliferation: MCT2 knock-down reduced PCa cell growth, and re-expression of MCT2 variants unable to localize to peroxisomes did not rescue proliferation, whereas peroxisome-targeted MCT2 did.","method":"siRNA knockdown, rescue with localization-variant constructs, proliferation assays","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with localization-specific rescue experiment; single lab","pmids":["33121137"],"is_preprint":false},{"year":2015,"finding":"Epigenetic demethylation of an internal SLC16A7/MCT2 promoter is a recurrent event in prostate cancer, driving expression of isoforms differing in 5'-UTR translational control motifs, contributing to MCT2 protein overexpression. Androgen receptor (AR) and ERG transcription factors bind at the SLC16A7 locus. MCT2 knockdown attenuated PCa cell growth.","method":"Bisulfite sequencing (methylation), integrative transcriptomic/epigenomic analysis, ChIP (AR/ERG), siRNA knockdown, cell proliferation assay","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms TF binding at locus, epigenetic mechanism supported by methylation data and isoform characterization; single lab","pmids":["26035357"],"is_preprint":false},{"year":2003,"finding":"MCT2 expression in spermatid tails is developmentally regulated, appearing at postnatal day 18 in elongating spermatids. MCT2 mRNA levels in testis are negatively regulated by FSH and testosterone (both reducing MCT2 mRNA in a dose-dependent manner in isolated seminiferous tubules), and also by TNF-α and TGF-β. Hypophysectomy caused an 8-fold increase in testicular MCT2 mRNA, reversed by FSH or LH administration.","method":"Northern blot, Western blot, immunoelectron microscopy, in vitro seminiferous tubule incubation with hormones, hypophysectomy model","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo hormonal manipulation plus in vitro dose-response; multiple methods; single lab","pmids":["12773420"],"is_preprint":false},{"year":2008,"finding":"In preimplantation mouse embryos, SLC16A7 (MCT2) protein localizes to apical cortical regions and vesicular/peroxisomal compartments (partially co-localizing with peroxisomal catalase), distinct from plasma membrane localization of MCT4. SLC16A7 expression is upregulated in the absence of glucose, in contrast to MCT1 and MCT4 which require glucose, suggesting a unique role in peroxisomal redox regulation.","method":"Immunofluorescence localization, co-localization with peroxisomal catalase, Western blot, mRNA analysis under varying glucose conditions","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — localization by immunofluorescence with functional context from glucose deprivation experiments; single lab","pmids":["18385447"],"is_preprint":false},{"year":2011,"finding":"BDNF injection into mouse hippocampal CA1 area enhanced MCT2 protein expression in vivo (confirmed by immunohistochemistry and immunoblot), co-occurring with upregulation of postsynaptic plasticity proteins PSD95 and GluR2 but not glial MCT1/MCT4, synaptic vesicle proteins, or αCaMKII. This places MCT2 upregulation in the context of BDNF-mediated synaptic plasticity.","method":"Intrahippocampal BDNF injection, immunohistochemistry, Western blot","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vivo demonstration of MCT2 upregulation by BDNF with selective protein panel; single lab, single method set","pmids":["21736920"],"is_preprint":false},{"year":2020,"finding":"AAV2-mediated overexpression of MCT2 in retinal ganglion cells (RGCs) of two glaucoma models preserved RGC density, axon number, and function (pattern ERG), reduced energy imbalance, and increased mitochondrial function (cytochrome c oxidase and succinate dehydrogenase activity). Conditional reduction of MCT2 in RGCs via AAV2-Cre in MCT2fl/+ mice caused significant decline in ATP production and visual evoked potential.","method":"AAV2-GFP-MCT2 intraocular injection, AAV2-Cre conditional KO, pattern ERG, RGC density quantification, enzyme activity assays (COX, SDH), ATP measurement","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO plus overexpression rescue in two disease models with multiple functional readouts; single lab but multiple orthogonal methods","pmids":["32422282"],"is_preprint":false},{"year":2025,"finding":"Deletion of MCT2 specifically in oligodendrocytes did not affect oligodendrocyte survival but resulted in downregulation of lipid synthesis-associated enzymes and failure of myelin maintenance. Concomitant axonal upregulation of lactate dehydrogenase A and axonal damage were observed. Ketogenic diet alleviated the axonal damage phenotype. MCT2 is expressed by myelinating oligodendrocytes in both mice and humans and is downregulated in progressive multiple sclerosis.","method":"Conditional KO in oligodendrocytes, immunohistochemistry, enzyme expression analysis, ketogenic diet intervention, human MS tissue analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific conditional KO with defined myelin and axonal phenotype; preprint, not yet peer-reviewed","pmids":[],"is_preprint":true},{"year":2025,"finding":"AAV-mediated expression of MCT2 in retinal pigment epithelium (RPE) cells promoted cone survival and function in rat and mouse retinitis pigmentosa models. FLIM biosensors showed changes in lactate and glucose levels within MCT2-expressing RPE, suggesting MCT2 in RPE promotes lactate uptake from blood, alters RPE metabolism, and increases glucose availability to cones.","method":"AAV gene delivery to RPE, ERG and visual function testing, fluorescence lifetime imaging (FLIM) biosensors for lactate and glucose in vivo","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gene delivery with functional rescue and direct metabolite imaging; single lab","pmids":["40178895"],"is_preprint":false},{"year":2025,"finding":"MCT2 knockdown in arcuate nucleus neurons of female rats (via AAV-shRNA) significantly increased food intake and body weight after fasting/refeeding, demonstrating that neuronal MCT2-mediated lactate transport in hypothalamic arcuate nucleus is required for normal satiety signaling. MCT2 KD also led to compensatory inhibition of MCT1, suggesting glial adaptation to increased parenchymal lactate.","method":"AAV-shRNA knockdown in arcuate nucleus, real-time PCR, Western blot, immunohistochemistry, feeding behavior analysis (macro/microstructure)","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — region-specific neuronal KD with defined behavioral phenotype and molecular compensation; single lab","pmids":["40032881"],"is_preprint":false},{"year":2025,"finding":"Lactate transport via neuronal MCT2 is not required for sustained synchronized synaptic transmission (gamma oscillations or sharp wave-ripples) in hippocampal slices supplied with glucose. MCT1/2 blockade by AR-C155858 did not affect gamma oscillation properties when glucose was the energy supply, but fully suppressed oscillations when lactate was the sole substrate. Intracellular lactate accumulation in neurons upon MCT1/2 blockade was confirmed by FRET sensor imaging.","method":"Local field potential recordings, pharmacological MCT1/2 blockade (AR-C155858), UPLC-MS lactate measurement, FRET (Laconic sensor) imaging in neuron-astrocyte cultures","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple electrophysiology and metabolic readouts with pharmacological MCT blockade; negative finding (not required for glucose-supported oscillations) is mechanistically informative","pmids":["41048117"],"is_preprint":false},{"year":2025,"finding":"β-catenin directly binds to and transcriptionally activates the MCT2 promoter (confirmed by ChIP-qPCR with JASPAR motif prediction). β-catenin overexpression markedly increased MCT2 mRNA and protein. The β-catenin/c-Myc/MCT2 signaling axis regulates mitochondrial energy metabolism; gastrodin stabilizes β-catenin protein (confirmed by DARTS and CETSA), increasing MCT2 expression and pyruvate/ATP levels in AD models.","method":"ChIP-qPCR (β-catenin at MCT2 promoter), lentiviral β-catenin overexpression, Western blot, qPCR, DARTS, CETSA, ATP/pyruvate assays","journal":"Journal of ethnopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms direct transcriptional regulation; multiple orthogonal methods for pathway; single lab","pmids":["40915373"],"is_preprint":false},{"year":2025,"finding":"Neuronal MCT2 is required for WS (whisker stimulation)-induced angiogenesis in neonatal mouse neocortex. MCT2 facilitates L-lactate influx into cortex, promoting lactate uptake by neurons and astrocytes, which activates HIF1α and VEGFa expression in astrocytes, driving angiogenesis. Neuronal MCT2 loss-of-function abolished these angiogenic and metabolic responses.","method":"RNA-seq, RNA-scope spatial transcriptomics, genetic loss-of-function, lactate measurements, immunofluorescence for VEGFa/HIF1α, vascular density quantification","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic LOF with multiple molecular readouts placing MCT2 in HIF1α/VEGF pathway; single lab","pmids":["41046267"],"is_preprint":false}],"current_model":"SLC16A7/MCT2 is a high-affinity, proton-coupled monocarboxylate transporter (preferring pyruvate, lactate, and ketone bodies) that requires an ancillary protein—embigin (gp70) or, in some cell types, neuroplastins or basigin—for plasma membrane expression and activity; in neurons it localizes to postsynaptic densities where it co-traffics with AMPA receptor GluR2/3 subunits under control of the PI3K–Akt–mTOR–S6K translational pathway, while in prostate cancer cells it localizes to peroxisomes via Pex19 to support β-oxidation, and in oligodendrocytes it maintains myelin integrity; its transport activity can be augmented non-catalytically by extracellular carbonic anhydrase IV and inhibited by AR-C155858 binding to an intracellular site on TMs 7–10."},"narrative":{"mechanistic_narrative":"SLC16A7/MCT2 is a high-affinity, proton-coupled monocarboxylate transporter that moves pyruvate, lactate, and ketone bodies across membranes to support cellular energy metabolism [PMID:7829520, PMID:10417314, PMID:9786900]. It distinguishes itself from other MCTs by its high substrate affinity (lactate Km ~0.74 mM; pyruvate Km ~25 µM) and by its insensitivity to organomercurial thiol reagents [PMID:10417314, PMID:9786900], a property explained by its preferential association with the ancillary protein embigin (gp70) rather than basigin/CD147 for plasma-membrane expression [PMID:15917240]; neuroplastins serve this chaperone role in neural tissue, and basigin substitutes in spermatozoa, indicating cell-type-specific ancillary partnerships [PMID:24260123, PMID:21792931]. The ancillary protein modulates inhibitor sensitivity and surface delivery, while the transmembrane domains (TM7–12) set substrate affinity; the small-molecule inhibitor AR-C155858 binds an intracellular site formed by TMs 7–10, and extracellular carbonic anhydrase IV non-catalytically augments transport when embigin is present [PMID:19929853, PMID:20695846, PMID:21680735]. In neurons, MCT2 is a postsynaptic density protein at glutamatergic synapses that co-distributes and co-traffics with AMPA receptor GluR2/3 subunits and PICK1, with surface delivery tied to neuronal lactate uptake and its protein levels controlled translationally through the PI3K–Akt–mTOR–S6K pathway downstream of insulin/IGF-1 and noradrenaline [PMID:11291733, PMID:15749979, PMID:19453627, PMID:18093179, PMID:17394554, PMID:19457092]. Neuronal MCT2-mediated lactate transport is required for activity-dependent metabolic and hemodynamic responses, angiogenesis, hypothalamic satiety signaling, and is neuroprotective in retinal and myelin contexts [PMID:28388627, PMID:40032881, PMID:41046267, PMID:32422282]. In prostate cancer, MCT2 is redirected to peroxisomes via interaction with Pex19, where its peroxisomal localization supports β-oxidation and is required for proliferation, and its overexpression is driven by demethylation of an internal SLC16A7 promoter [PMID:25639644, PMID:33121137, PMID:26035357]. MCT2 also governs the intracellular delivery and consequent activity of the small-molecule methyloxalylglycine, dictating its metabolic and cytotoxic mode of action [PMID:30297875, PMID:36028752]. No Mendelian disease link is established in the available corpus.","teleology":[{"year":1998,"claim":"Establishing the core identity of MCT2 required showing it is a proton-coupled monocarboxylate transporter, which defined its basic transport function and substrate selectivity.","evidence":"Heterologous expression in Sf9 insect cells and Xenopus oocytes with radiolabeled transport and pharmacological inhibition; cDNA cloning and FISH mapping to 12q13","pmids":["7829520","10417314","9786900"],"confidence":"High","gaps":["No structural model of the transporter resolved","Stoichiometry of H+/monocarboxylate coupling not fully defined in these studies"]},{"year":1999,"claim":"Quantitative kinetics established MCT2 as a high-affinity transporter (~10-fold higher affinity than MCT1) with a broad ketone-body/branched-keto-acid substrate range, explaining its niche in tissues requiring efficient low-substrate uptake.","evidence":"Xenopus oocyte radiolabeled transport assays with multiple substrates and inhibition kinetics","pmids":["10417314"],"confidence":"High","gaps":["Tissue-level relevance of each substrate not addressed","Does not distinguish import vs export directionality in vivo"]},{"year":2005,"claim":"Identifying embigin rather than basigin as the obligate ancillary protein answered how MCT2 reaches the plasma membrane and mechanistically explained its distinct pharmacology (pCMBS insensitivity).","evidence":"Co-immunoprecipitation, FRET with CFP/YFP-tagged proteins, and site-directed mutagenesis of CD147","pmids":["15917240"],"confidence":"High","gaps":["Stoichiometry of MCT2-embigin complex not defined","Did not test whether embigin is universally required across all tissues"]},{"year":2010,"claim":"Mapping the AR-C155858 binding site and showing the ancillary protein modulates inhibitor sensitivity defined which protein domains govern transport versus drug response, separating substrate affinity (TM domains) from inhibitor sensitivity (ancillary-dependent).","evidence":"Xenopus oocyte expression with chimeric/truncation constructs, microinjection, ancillary protein swaps, and inhibitor titrations","pmids":["19929853","20695846"],"confidence":"High","gaps":["No co-crystal structure of inhibitor bound","Conformational mechanism of ancillary modulation unresolved"]},{"year":2011,"claim":"Demonstrating that extracellular carbonic anhydrase IV augments MCT2 transport non-catalytically revealed a regulatory partner that boosts flux independent of pH-buffering enzymatic activity.","evidence":"Xenopus oocyte co-expression with catalytically inactive CAIV mutants and pharmacological inhibition of CA activity","pmids":["21680735"],"confidence":"High","gaps":["Physiological context of CAIV-MCT2 interaction not established in native tissue","Molecular interaction surface between CAIV and the MCT2-embigin complex undefined"]},{"year":2013,"claim":"Identifying neuroplastins as MCT2 ancillary proteins explained how MCT2 achieves surface expression in neural tissue where embigin distribution may be limited.","evidence":"COS-7 co-transfection, Xenopus oocyte antisense knockdown, immunocytochemistry, and lactate transport assays","pmids":["24260123"],"confidence":"High","gaps":["Relative contribution of neuroplastin vs embigin in individual neuron types not quantified","Whether neuroplastin alters inhibitor sensitivity not tested"]},{"year":2009,"claim":"Defining MCT2 as a postsynaptic density protein that physically and functionally co-traffics with AMPA receptor GluR2/3 and PICK1 connected lactate transport to activity-dependent synaptic delivery and metabolic support of excitatory neurons.","evidence":"Immunogold EM, reciprocal co-IP, surface biotinylation, parallel trafficking experiments, and fluorescent lactate flux assays","pmids":["11291733","15749979","19453627","19457092"],"confidence":"High","gaps":["Whether MCT2 trafficking is causally required for AMPA receptor trafficking versus co-regulated unresolved","Functional consequence of vesicular MCT2 pool not directly measured"]},{"year":2007,"claim":"Showing MCT2 protein is upregulated translationally via PI3K-Akt-mTOR-S6K by noradrenaline, insulin, IGF-1, and BDNF established that neuronal MCT2 abundance is a tunable, signal-responsive node rather than transcriptionally fixed.","evidence":"Western blot with mRNA/protein dissociation, selective pathway inhibitors, and in vivo BDNF injection with immunohistochemistry","pmids":["17394554","18093179","21736920"],"confidence":"Medium","gaps":["No genetic rescue to confirm pathway specificity","Direct mRNA targets/translational control elements not identified"]},{"year":2015,"claim":"Discovery of peroxisomal MCT2 localization via Pex19 in prostate cancer revealed an organelle-specific role distinct from plasma-membrane transport, linking MCT2 to β-oxidation and malignant proliferation.","evidence":"Co-localization with peroxisomal markers, co-IP with Pex19, localization-variant rescue of proliferation, bisulfite methylation analysis, and ChIP for AR/ERG","pmids":["25639644","33121137","26035357"],"confidence":"Medium","gaps":["Substrate transported by peroxisomal MCT2 not directly demonstrated","Mechanism connecting peroxisomal transport to proliferation undefined","Whether embigin/ancillary protein participates in peroxisomal targeting unknown"]},{"year":2018,"claim":"Showing MCT2 controls cellular uptake of methyloxalylglycine and thereby dictates its metabolic mode of action established MCT2 as a determinant of small-molecule pharmacology and intracellular drug concentration.","evidence":"LC-MS metabolomics, MCT2 KD/KO, transport assays, respiration assays, and SAR with MOG analogues","pmids":["30297875","36028752"],"confidence":"High","gaps":["Generality to other monocarboxylate-mimetic drugs not established","Native physiological substrate competition with such drugs not quantified"]},{"year":2017,"claim":"Demonstrating transcriptional control of MCT2 by Notch/Hes1 and β-catenin, and lactate-mediated c-Jun stabilization, placed MCT2 within signaling networks where lactate import acts as a metabolic and signaling input.","evidence":"ChIP for Hes1 and β-catenin at the MCT2 locus, LC-MS lactate-c-Jun interaction, CRISPR-Cas9 KO, and DARTS/CETSA","pmids":["35263597","40915373"],"confidence":"Medium","gaps":["Direct lactate-c-Jun binding mode not structurally resolved","Cell-type generality of β-catenin/c-Myc/MCT2 axis not established"]},{"year":2019,"claim":"In vivo neuronal MCT2 knockdown studies established that MCT2-mediated lactate transport is functionally required for activity-dependent metabolic responses, neurovascular coupling, angiogenesis, satiety signaling, and neuroprotection.","evidence":"Lentiviral/AAV shRNA and conditional KO with NMR/13C-labeling, fMRI, RNA-seq, feeding behavior, ERG, and enzyme/ATP assays across cortex, hypothalamus, retina, and oligodendrocytes","pmids":["28388627","32422282","40032881","41046267","40178895"],"confidence":"High","gaps":["Quantitative contribution of MCT2 versus other MCTs in each tissue not fully isolated","Whether transport per se or protein-protein scaffolding drives some phenotypes unresolved"]},{"year":2025,"claim":"Cell-type-specific MCT2 deletion and pharmacological blockade refined when lactate transport is dispensable versus essential, showing it is required for myelin maintenance and lactate-only-fueled oscillations but not for glucose-supported synaptic transmission.","evidence":"Oligodendrocyte conditional KO with ketogenic-diet rescue and human MS tissue analysis; LFP recordings with AR-C155858 and FRET lactate sensors","pmids":["41048117"],"confidence":"Medium","gaps":["Oligodendrocyte KO finding is from a preprint not yet peer-reviewed","Mechanism linking MCT2 loss to lipid-synthesis enzyme downregulation undefined"]},{"year":null,"claim":"How MCT2 is sorted between plasma membrane, peroxisomes, and mitochondria in different cell types, and what governs the choice of ancillary partner, remains the central unresolved question.","evidence":"No reconciling study in the available corpus addresses the targeting determinants across organelles and tissues","pmids":[],"confidence":"Low","gaps":["No structural basis for substrate selectivity or organelle targeting","Mechanism dictating embigin vs neuroplastin vs basigin choice unknown","Direct demonstration of peroxisomal/mitochondrial transport substrate lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,1,15]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,8,9,10]},{"term_id":"GO:0005777","term_label":"peroxisome","supporting_discovery_ids":[20,21,24]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[9,18]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,15,19]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,1,2]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[8,9,10,19]}],"complexes":[],"partners":["EMB","NPTN","BSG","CA4","GRIA2","PICK1","PEX19","AQP9"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O60669","full_name":"Monocarboxylate transporter 2","aliases":["Solute carrier family 16 member 7"],"length_aa":478,"mass_kda":52.2,"function":"Proton-coupled monocarboxylate symporter. Catalyzes the rapid transport across the plasma membrane of monocarboxylates such as L-lactate, pyruvate and ketone bodies, acetoacetate, beta-hydroxybutyrate and acetate (PubMed:32415067, PubMed:9786900). Dimerization is functionally required and both subunits work cooperatively in transporting substrate (PubMed:32415067)","subcellular_location":"Cell membrane; Basolateral cell membrane; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/O60669/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC16A7","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLC16A7","total_profiled":1310},"omim":[{"mim_id":"603877","title":"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 3; SLC16A3","url":"https://www.omim.org/entry/603877"},{"mim_id":"603654","title":"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 7; SLC16A7","url":"https://www.omim.org/entry/603654"},{"mim_id":"600682","title":"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 1; SLC16A1","url":"https://www.omim.org/entry/600682"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":18.8},{"tissue":"heart muscle","ntpm":32.2}],"url":"https://www.proteinatlas.org/search/SLC16A7"},"hgnc":{"alias_symbol":["MCT2"],"prev_symbol":[]},"alphafold":{"accession":"O60669","domains":[{"cath_id":"1.20.1250.20","chopping":"13-198","consensus_level":"medium","plddt":93.5532,"start":13,"end":198},{"cath_id":"1.20.1250.20","chopping":"238-444","consensus_level":"medium","plddt":93.8002,"start":238,"end":444}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60669","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60669-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60669-F1-predicted_aligned_error_v6.png","plddt_mean":84.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC16A7","jax_strain_url":"https://www.jax.org/strain/search?query=SLC16A7"},"sequence":{"accession":"O60669","fasta_url":"https://rest.uniprot.org/uniprotkb/O60669.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60669/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60669"}},"corpus_meta":[{"pmid":"7829520","id":"PMC_7829520","title":"cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7829520","citation_count":294,"is_preprint":false},{"pmid":"15917240","id":"PMC_15917240","title":"Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70).","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15917240","citation_count":255,"is_preprint":false},{"pmid":"10417314","id":"PMC_10417314","title":"Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.","date":"1999","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10417314","citation_count":242,"is_preprint":false},{"pmid":"19929853","id":"PMC_19929853","title":"AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19929853","citation_count":208,"is_preprint":false},{"pmid":"11098125","id":"PMC_11098125","title":"Cell-specific localization of monocarboxylate transporters, MCT1 and MCT2, in the adult mouse brain revealed by double immunohistochemical labeling and confocal microscopy.","date":"2000","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11098125","citation_count":199,"is_preprint":false},{"pmid":"14622911","id":"PMC_14622911","title":"Highly differential expression of the monocarboxylate transporters MCT2 and MCT4 in the developing rat brain.","date":"2003","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14622911","citation_count":181,"is_preprint":false},{"pmid":"9786900","id":"PMC_9786900","title":"Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9786900","citation_count":175,"is_preprint":false},{"pmid":"11973431","id":"PMC_11973431","title":"MCT2 is a major neuronal monocarboxylate transporter in the adult mouse brain.","date":"2002","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11973431","citation_count":163,"is_preprint":false},{"pmid":"19876643","id":"PMC_19876643","title":"Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes.","date":"2009","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19876643","citation_count":137,"is_preprint":false},{"pmid":"11291733","id":"PMC_11291733","title":"A novel postsynaptic density protein: the monocarboxylate transporter MCT2 is co-localized with delta-glutamate receptors in postsynaptic densities of parallel fiber-Purkinje cell synapses.","date":"2001","source":"Experimental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11291733","citation_count":134,"is_preprint":false},{"pmid":"9182702","id":"PMC_9182702","title":"Cloning of the monocarboxylate transporter isoform MCT2 from rat testis provides evidence that expression in tissues is species-specific and may involve post-transcriptional regulation.","date":"1997","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9182702","citation_count":122,"is_preprint":false},{"pmid":"9482213","id":"PMC_9482213","title":"Expression of the monocarboxylate transporter MCT2 by rat brain glia.","date":"1998","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/9482213","citation_count":106,"is_preprint":false},{"pmid":"10794666","id":"PMC_10794666","title":"Monocarboxylic acid transporters, MCT1 and MCT2, in cortical astrocytes in vitro and in vivo.","date":"2000","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10794666","citation_count":102,"is_preprint":false},{"pmid":"24610532","id":"PMC_24610532","title":"Acute exercise increases brain region-specific expression of MCT1, MCT2, MCT4, GLUT1, and COX IV proteins.","date":"2014","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/24610532","citation_count":93,"is_preprint":false},{"pmid":"19401710","id":"PMC_19401710","title":"Enhanced cerebral expression of MCT1 and MCT2 in a rat ischemia model occurs in activated microglial cells.","date":"2009","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19401710","citation_count":92,"is_preprint":false},{"pmid":"10392858","id":"PMC_10392858","title":"Distribution of monocarboxylate transporters MCT1 and MCT2 in rat retina.","date":"1999","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10392858","citation_count":91,"is_preprint":false},{"pmid":"15749979","id":"PMC_15749979","title":"Selective postsynaptic co-localization of MCT2 with AMPA receptor GluR2/3 subunits at excitatory synapses exhibiting AMPA receptor trafficking.","date":"2005","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/15749979","citation_count":91,"is_preprint":false},{"pmid":"35263597","id":"PMC_35263597","title":"Notch-mediated lactate metabolism regulates MDSC development through the Hes1/MCT2/c-Jun axis.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35263597","citation_count":85,"is_preprint":false},{"pmid":"15932892","id":"PMC_15932892","title":"Immunohistochemical analysis of MCT1, MCT2 and MCT4 expression in rat plantaris muscle.","date":"2005","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15932892","citation_count":80,"is_preprint":false},{"pmid":"20695846","id":"PMC_20695846","title":"The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20695846","citation_count":79,"is_preprint":false},{"pmid":"18523157","id":"PMC_18523157","title":"PGC-1alpha increases skeletal muscle lactate uptake by increasing the expression of MCT1 but not MCT2 or MCT4.","date":"2008","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18523157","citation_count":74,"is_preprint":false},{"pmid":"23638108","id":"PMC_23638108","title":"MCT2 expression and lactate influx in anorexigenic and orexigenic neurons of the arcuate nucleus.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23638108","citation_count":58,"is_preprint":false},{"pmid":"18093179","id":"PMC_18093179","title":"Insulin and IGF-1 enhance the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin pathway.","date":"2007","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18093179","citation_count":52,"is_preprint":false},{"pmid":"25639644","id":"PMC_25639644","title":"Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer.","date":"2015","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25639644","citation_count":50,"is_preprint":false},{"pmid":"17394554","id":"PMC_17394554","title":"Noradrenaline enhances the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of PI3K/Akt and the mTOR/S6K pathway.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17394554","citation_count":47,"is_preprint":false},{"pmid":"21680735","id":"PMC_21680735","title":"Transport activity of the high-affinity monocarboxylate transporter MCT2 is enhanced by extracellular carbonic anhydrase IV but not by intracellular carbonic anhydrase II.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21680735","citation_count":45,"is_preprint":false},{"pmid":"12773420","id":"PMC_12773420","title":"Developmental and hormonal regulation of the monocarboxylate transporter 2 (MCT2) expression in the mouse germ cells.","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/12773420","citation_count":42,"is_preprint":false},{"pmid":"21736920","id":"PMC_21736920","title":"Brain-derived neurotrophic factor enhances the hippocampal expression of key postsynaptic proteins in vivo including the monocarboxylate transporter MCT2.","date":"2011","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21736920","citation_count":42,"is_preprint":false},{"pmid":"23192371","id":"PMC_23192371","title":"Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer.","date":"2012","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/23192371","citation_count":41,"is_preprint":false},{"pmid":"32422282","id":"PMC_32422282","title":"MCT2 overexpression rescues metabolic vulnerability and protects retinal ganglion cells in two models of glaucoma.","date":"2020","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/32422282","citation_count":41,"is_preprint":false},{"pmid":"35939682","id":"PMC_35939682","title":"Whole-brain neuronal MCT2 lactate transporter expression links metabolism to human brain structure and function.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35939682","citation_count":40,"is_preprint":false},{"pmid":"28388627","id":"PMC_28388627","title":"A neuronal MCT2 knockdown in the rat somatosensory cortex reduces both the NMR lactate signal and the BOLD response during whisker stimulation.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28388627","citation_count":40,"is_preprint":false},{"pmid":"12966567","id":"PMC_12966567","title":"Perinatal and early postnatal changes in the expression of monocarboxylate transporters MCT1 and MCT2 in the rat forebrain.","date":"2003","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12966567","citation_count":39,"is_preprint":false},{"pmid":"30312017","id":"PMC_30312017","title":"Curcumin Ameliorates Memory Deficits by Enhancing Lactate Content and MCT2 Expression in APP/PS1 Transgenic Mouse Model of Alzheimer's Disease.","date":"2018","source":"Anatomical record (Hoboken, N.J. : 2007)","url":"https://pubmed.ncbi.nlm.nih.gov/30312017","citation_count":35,"is_preprint":false},{"pmid":"21792931","id":"PMC_21792931","title":"Basigin interacts with both MCT1 and MCT2 in murine spermatozoa.","date":"2012","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21792931","citation_count":32,"is_preprint":false},{"pmid":"19453627","id":"PMC_19453627","title":"Linking supply to demand: the neuronal monocarboxylate transporter MCT2 and the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionic acid receptor GluR2/3 subunit are associated in a common trafficking process.","date":"2009","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19453627","citation_count":32,"is_preprint":false},{"pmid":"26299481","id":"PMC_26299481","title":"Immunohistochemical localization of GLUT3, MCT1, and MCT2 in the testes of mice and rats: the use of different energy sources in spermatogenesis.","date":"2015","source":"Biomedical research (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/26299481","citation_count":30,"is_preprint":false},{"pmid":"16901736","id":"PMC_16901736","title":"Expression of CD147 and monocarboxylate transporters MCT1, MCT2 and MCT4 in porcine small intestine and colon.","date":"2006","source":"Veterinary journal (London, England : 1997)","url":"https://pubmed.ncbi.nlm.nih.gov/16901736","citation_count":29,"is_preprint":false},{"pmid":"15953554","id":"PMC_15953554","title":"Expression of MCT1, MCT2 and MCT4 in the rumen, small intestine and liver of reindeer (Rangifer tarandus tarandus L.).","date":"2005","source":"Comparative biochemistry and physiology. Part A, Molecular & integrative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15953554","citation_count":29,"is_preprint":false},{"pmid":"30297875","id":"PMC_30297875","title":"MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG.","date":"2018","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/30297875","citation_count":26,"is_preprint":false},{"pmid":"24260123","id":"PMC_24260123","title":"The neuroplastin adhesion molecules are accessory proteins that chaperone the monocarboxylate transporter MCT2 to the neuronal cell surface.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24260123","citation_count":26,"is_preprint":false},{"pmid":"26035357","id":"PMC_26035357","title":"Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26035357","citation_count":24,"is_preprint":false},{"pmid":"12492781","id":"PMC_12492781","title":"Distribution of monocarboxylate transporter isoforms MCT1, MCT2 and MCT4 in porcine muscles.","date":"2003","source":"Acta physiologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/12492781","citation_count":24,"is_preprint":false},{"pmid":"18385447","id":"PMC_18385447","title":"Characterization and regulation of monocarboxylate cotransporters Slc16a7 and Slc16a3 in preimplantation mouse embryos.","date":"2008","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/18385447","citation_count":23,"is_preprint":false},{"pmid":"18598673","id":"PMC_18598673","title":"Distribution of the monocarboxylate transporter MCT2 in human cerebral cortex: an immunohistochemical study.","date":"2008","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/18598673","citation_count":23,"is_preprint":false},{"pmid":"37522672","id":"PMC_37522672","title":"Targeting the monocarboxylate transporter MCT2 and lactate dehydrogenase A LDHA in cancer cells with FX-11 and AR-C155858 inhibitors.","date":"2023","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37522672","citation_count":18,"is_preprint":false},{"pmid":"19404741","id":"PMC_19404741","title":"Metabolic effects of blocking lactate transport in brain cortical tissue slices using an inhibitor specific to MCT1 and MCT2.","date":"2009","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/19404741","citation_count":18,"is_preprint":false},{"pmid":"34234890","id":"PMC_34234890","title":"MCT2 overexpression promotes recovery of cognitive function by increasing mitochondrial biogenesis in a rat model of stroke.","date":"2021","source":"Animal cells and systems","url":"https://pubmed.ncbi.nlm.nih.gov/34234890","citation_count":16,"is_preprint":false},{"pmid":"33121137","id":"PMC_33121137","title":"Prostate Cancer Proliferation Is Affected by the Subcellular Localization of MCT2 and Accompanied by Significant Peroxisomal Alterations.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33121137","citation_count":15,"is_preprint":false},{"pmid":"36358250","id":"PMC_36358250","title":"SLC16A7 Promotes Triglyceride Deposition by De Novo Lipogenesis in Chicken Muscle Tissue.","date":"2022","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/36358250","citation_count":13,"is_preprint":false},{"pmid":"23417128","id":"PMC_23417128","title":"Expression and cellular localization of monocarboxylate transporters (MCT2, MCT7, and MCT8) along the cattle gastrointestinal tract.","date":"2013","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/23417128","citation_count":13,"is_preprint":false},{"pmid":"19457092","id":"PMC_19457092","title":"Regulation of the intracellular distribution, cell surface expression, and protein levels of AMPA receptor GluR2 subunits by the monocarboxylate transporter MCT2 in neuronal cells.","date":"2009","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19457092","citation_count":13,"is_preprint":false},{"pmid":"9447934","id":"PMC_9447934","title":"Functional evidence for a monocarboxylate transporter (MCT) in strial marginal cells and molecular evidence for MCT1 and MCT2 in stria vascularis.","date":"1997","source":"Hearing research","url":"https://pubmed.ncbi.nlm.nih.gov/9447934","citation_count":13,"is_preprint":false},{"pmid":"24799634","id":"PMC_24799634","title":"The genetic variation in monocarboxylic acid transporter 2 (MCT2) has functional and clinical relevance with male infertility.","date":"2014","source":"Asian journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/24799634","citation_count":11,"is_preprint":false},{"pmid":"30347438","id":"PMC_30347438","title":"Neuroprotective effect of rLosac on supplement-deprived mouse cultured cortical neurons involves maintenance of monocarboxylate transporter MCT2 protein levels.","date":"2018","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30347438","citation_count":11,"is_preprint":false},{"pmid":"25161606","id":"PMC_25161606","title":"Glutamate reduces glucose utilization while concomitantly enhancing AQP9 and MCT2 expression in cultured rat hippocampal neurons.","date":"2014","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25161606","citation_count":9,"is_preprint":false},{"pmid":"21059000","id":"PMC_21059000","title":"Expression of lactate transporters MCT1, MCT2 and CD147 in the red blood cells of three horse breeds: Finnhorse, Standardbred and Thoroughbred.","date":"2010","source":"Equine veterinary journal. Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/21059000","citation_count":7,"is_preprint":false},{"pmid":"40178895","id":"PMC_40178895","title":"RPE-specific MCT2 expression promotes cone survival in models of retinitis pigmentosa.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40178895","citation_count":4,"is_preprint":false},{"pmid":"41048117","id":"PMC_41048117","title":"Lactate Transport via Glial MCT1 and Neuronal MCT2 Is Not Required for Synchronized Synaptic Transmission in Hippocampal Slices Supplied With Glucose.","date":"2025","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41048117","citation_count":3,"is_preprint":false},{"pmid":"40915373","id":"PMC_40915373","title":"Gastrodin alleviates mitochondrial energy metabolism dysfunction via activating β-catenin/c-Myc/MCT2 signaling in Alzheimer's disease models.","date":"2025","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40915373","citation_count":3,"is_preprint":false},{"pmid":"40032881","id":"PMC_40032881","title":"Knocking down the neuronal lactate transporter MCT2 in the arcuate nucleus of female rats increases food intake and body weight.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40032881","citation_count":3,"is_preprint":false},{"pmid":"39934699","id":"PMC_39934699","title":"The interactions between monocarboxylate transporter genes MCT1, MCT2, and MCT4 and the kinetics of blood lactate production and removal after high-intensity efforts in elite males: a cross-sectional study.","date":"2025","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/39934699","citation_count":3,"is_preprint":false},{"pmid":"39215860","id":"PMC_39215860","title":"Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma.","date":"2024","source":"European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/39215860","citation_count":2,"is_preprint":false},{"pmid":"41046267","id":"PMC_41046267","title":"Neuronal MCT2 promotes angiogenesis via lactate in the developing mouse neocortex.","date":"2025","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/41046267","citation_count":2,"is_preprint":false},{"pmid":"36028752","id":"PMC_36028752","title":"MOG analogues to explore the MCT2 pharmacophore, α-ketoglutarate biology and cellular effects of N-oxalylglycine.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/36028752","citation_count":2,"is_preprint":false},{"pmid":"40869186","id":"PMC_40869186","title":"Associations Between Genetic Variants in MCT2 (rs3763980, rs995343, rs3763979) and MCT4 (rs11323780) with Blood Lactate Kinetics Before and After Supramaximal Exercise.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40869186","citation_count":1,"is_preprint":false},{"pmid":"31368261","id":"PMC_31368261","title":"[Acupuncture up-regulates MCT2 expression of peri-ischemic cortex in middle cerebral artery occlusion rats].","date":"2019","source":"Zhen ci yan jiu = Acupuncture research","url":"https://pubmed.ncbi.nlm.nih.gov/31368261","citation_count":1,"is_preprint":false},{"pmid":"40410718","id":"PMC_40410718","title":"Tumor suppressing function of SLC16A7 in bladder cancer and its pan-cancer analysis.","date":"2025","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/40410718","citation_count":0,"is_preprint":false},{"pmid":"40930456","id":"PMC_40930456","title":"Acute restraint stress and epinephrine administration disrupt cognitive and emotional functions in male rats via modulation of proinflammatory cytokines, MCT-2, and neurogranin.","date":"2025","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/40930456","citation_count":0,"is_preprint":false},{"pmid":"42137367","id":"PMC_42137367","title":"Compensatory transporter upregulation facilitates retinal ganglion cell survival in glaucoma after MCT2 elimination.","date":"2026","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/42137367","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.01.10.632306","title":"Monocarboxylate transporter 2 is required for the maintenance of myelin and axonal integrity by oligodendrocytes","date":"2025-01-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.10.632306","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":39671,"output_tokens":8822,"usd":0.125671,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18824,"output_tokens":4968,"usd":0.10916,"stage2_stop_reason":"end_turn"},"total_usd":0.234831,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"MCT2 (SLC16A7) transports pyruvate and lactate in a proton-coupled manner; it is sensitive to phloretin and alpha-cyano-4-hydroxycinnamate but insensitive to organomercurial thiol reagents (e.g., p-chloromercuribenzoic acid), distinguishing it from MCT1. Functional activity was demonstrated by expression in Sf9 insect cells using recombinant baculovirus vectors.\",\n      \"method\": \"Heterologous expression in Sf9 insect cells (baculovirus), transport assays, pharmacological inhibition, immunoblotting/immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct reconstitution of transport activity in heterologous expression system with pharmacological characterization; foundational study replicated extensively\",\n      \"pmids\": [\"7829520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MCT2 is a high-affinity H+/monocarboxylate transporter with Km ~0.74 mM for lactate at pH 7.0 (approximately 10-fold higher affinity than MCT1). Substrates include lactate, pyruvate, β-hydroxybutyrate, acetoacetate, and branched-chain keto acids. Transport is driven by the H+ gradient and is inhibited by alpha-cyano-4-hydroxycinnamate, anion-channel inhibitors, and flavonoids.\",\n      \"method\": \"Heterologous expression in Xenopus laevis oocytes, radiolabeled transport assays, inhibition kinetics\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — detailed kinetic characterization in Xenopus oocyte expression system with multiple substrates and inhibitors; replicated across labs\",\n      \"pmids\": [\"10417314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Human MCT2 (SLC16A7) is a high-affinity pyruvate transporter with an apparent Km of ~25 µM for pyruvate, functioning as a H+/monocarboxylate cotransporter. The gene maps to chromosome 12q13.\",\n      \"method\": \"cDNA cloning, heterologous expression, kinetic transport assays, fluorescence in situ hybridization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct transport kinetics in heterologous expression system; independently consistent with other species characterizations\",\n      \"pmids\": [\"9786900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MCT2 associates with the ancillary protein embigin (gp70) rather than basigin (CD147) for plasma membrane expression, in contrast to MCT1 and MCT4 which associate with basigin. This interaction was confirmed by co-immunoprecipitation and FRET between CFP/YFP-tagged MCT2 and gp70. The MCT2-embigin association explains the insensitivity of MCT2 to pCMBS inhibition, because pCMBS targets the disulfide bridge in the Ig-like C2 domain of CD147.\",\n      \"method\": \"Co-immunoprecipitation, FRET (CFP/YFP-tagged proteins), site-directed mutagenesis of CD147, cell-impermeant organomercurial inhibitor assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reciprocal co-IP plus FRET plus mutagenesis in single study; mechanistically explains pharmacological phenotype\",\n      \"pmids\": [\"15917240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"AR-C155858 is a potent inhibitor of MCT2 (and MCT1) that binds to an intracellular site involving transmembrane helices 7–10. Inhibition is time-dependent and the compound is active when microinjected, confirming intracellular binding. MCT4 is not inhibited. Chimeric transporter experiments localized the binding site to the C-terminal half of MCT1 (and by extension MCT2).\",\n      \"method\": \"Xenopus oocyte expression, inhibitor titrations, microinjection, chimeric MCT1/MCT4 constructs, Km determination\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in heterologous system with chimeric constructs and microinjection to map binding site; replicated with multiple constructs\",\n      \"pmids\": [\"19929853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The ancillary protein associated with MCT2 modulates its sensitivity to AR-C155858: MCT2 expressed with endogenous Xenopus basigin is potently inhibited by AR-C155858, whereas MCT2 co-expressed with exogenous embigin is insensitive to AR-C155858. Embigin modulates MCT2 inhibitor sensitivity through interactions with the intracellular C-terminus and TMs 3 and 6. Lactate Km is determined primarily by the TM domains (TM7–12) of MCT2 and not by the associated ancillary protein.\",\n      \"method\": \"Xenopus oocyte expression, co-expression of embigin/basigin, chimeric and truncation constructs, inhibitor titrations, RT-PCR\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple chimeric constructs and ancillary protein swap in reconstituted oocyte system; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"20695846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Extracellular membrane-bound carbonic anhydrase IV (CAIV), but not cytosolic CAII, enhances transport activity of MCT2. CAIV augmentation of MCT2 is independent of CAIV catalytic activity (shown by ethoxyzolamide treatment and catalytically inactive CAIV-V165Y mutant) and does not require its intramolecular H+-shuttle residue His-88. Enhancement only occurs when MCT2 is co-expressed with its ancillary protein embigin (gp70).\",\n      \"method\": \"Xenopus oocyte co-expression, pharmacological inhibition, site-directed mutagenesis of CAIV, electrophysiological transport assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in Xenopus oocytes with mutagenesis and pharmacological controls; single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"21680735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Neuroplastins (np65 and np55), Ig superfamily adhesion molecules, act as ancillary proteins for MCT2, enabling its plasma membrane expression and lactate transport activity. Demonstrated by co-transfection in COS-7 cells, knockdown of endogenous Xenopus neuroplastin reducing MCT2 surface expression and transport, and co-localization of MCT2 and neuroplastins in rat cerebellum (parasagittal zebrin II-negative stripes).\",\n      \"method\": \"Co-transfection in COS-7 cells, Xenopus oocyte antisense RNA knockdown, immunocytochemistry, lactate transport assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (co-transfection, KD in oocytes, immunocytochemistry, transport assay); single lab\",\n      \"pmids\": [\"24260123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"MCT2 is concentrated at postsynaptic densities of parallel fiber–Purkinje cell synapses in cerebellum, co-localizing with delta2 glutamate receptors, as shown by immunogold electron microscopy. This identifies MCT2 as a novel postsynaptic density protein.\",\n      \"method\": \"Confocal immunofluorescence microscopy, double-labeling immunogold electron microscopy\",\n      \"journal\": \"Experimental brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — immunogold EM with quantitative double-labeling provides subcellular resolution; replicated in subsequent studies\",\n      \"pmids\": [\"11291733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MCT2 is selectively localized at postsynaptic densities of asymmetric (glutamatergic) synapses in hippocampal CA1 and CA3 and cerebellar parallel fiber–Purkinje cell synapses. MCT2 co-distributes quantitatively with AMPA receptor GluR2/3 subunits within postsynaptic densities. A significant intracellular vesicular pool of MCT2 exists within postsynaptic spines, suggesting endo/exocytotic trafficking analogous to AMPA receptors.\",\n      \"method\": \"Post-embedding electron microscopic immunocytochemistry, quantitative double-labeling immunogold\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — quantitative immunogold EM with double labeling at defined synapse types; replicated across brain regions and species\",\n      \"pmids\": [\"15749979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MCT2 co-immunoprecipitates with AMPA receptor GluR2/3 subunits and the GluR2/3-interacting protein PICK1 (C-kinase-interacting protein 1) in neurons, indicating a close physical interaction within dendritic spines. MCT2 and GluR2/3 undergo parallel membrane trafficking: AMPA or insulin stimulation causes intracellular accumulation of both, while TNF-α and glycine/glutamate increase their cell-surface expression. Surface translocation of MCT2 is associated with enhanced neuronal lactate uptake.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence co-localization, cell-surface biotinylation, Western blot on membrane/cytoplasm fractions, fluorescent lactate flux assay\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP plus parallel trafficking experiments with functional (lactate flux) validation; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"19453627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MCT2 protein expression in cultured cortical neurons is upregulated by insulin and IGF-1 through a translational (not transcriptional) mechanism requiring the PI3K–Akt–mTOR–S6K pathway. mTOR inhibitor rapamycin and PI3K inhibitor LY294002 almost completely blocked MCT2 protein upregulation, whereas MEK inhibitor PD98059 had no effect. The increase in MCT2 protein occurred in an intracellular pool without change at the cell surface.\",\n      \"method\": \"Western blot, qRT-PCR (no mRNA change), pharmacological pathway inhibitors, immunocytochemistry for subcellular localization\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple signaling inhibitors used to map pathway; single lab; no genetic rescue to confirm pathway specificity\",\n      \"pmids\": [\"18093179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Noradrenaline (NA) increases neuronal MCT2 protein expression via translational activation through the PI3K/Akt and mTOR/S6K pathway. LY294002 and rapamycin almost completely blocked NA-induced MCT2 upregulation, whereas MEK and p38 MAPK inhibitors had smaller effects. NA did not significantly alter MCT2 mRNA levels, confirming post-transcriptional regulation.\",\n      \"method\": \"Western blot, qRT-PCR, pharmacological inhibitors (LY294002, rapamycin, PD98059, SB202190), phosphorylation analyses\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway dissected with multiple selective inhibitors and mRNA/protein dissociation; single lab\",\n      \"pmids\": [\"17394554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MCT2 co-immunoprecipitates with AQP9 (aquaglyceroporin) from hippocampal neuron homogenates, and both proteins co-localize in mitochondria of hippocampal neurons. Glutamate exposure enhances protein (but not mRNA) expression of both MCT2 and AQP9 in these neurons.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence co-localization, Western blot, qRT-PCR\",\n      \"journal\": \"Frontiers in neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — co-IP and co-localization in single lab; mitochondrial localization inferred from co-localization, not fractionation validation\",\n      \"pmids\": [\"25161606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In murine spermatozoa, basigin (CD147) co-localizes and co-immunoprecipitates with both MCT1 and MCT2, whereas embigin interaction was not detectable. This differs from somatic cells where MCT2 preferentially associates with embigin. MCT-mediated L-lactate transport (measured as pHi decrease) in sperm was blocked by alpha-cyano-4-OH cinnamate.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence co-localization, intracellular pH measurement with fluorescent dye, ATP assay\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP with functional transport assay; single lab; cell-type-specific ancillary protein interaction\",\n      \"pmids\": [\"21792931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MCT2 mediates cellular uptake of methyloxalylglycine (MOG), the hydrolysis product of DMOG. MCT2-facilitated entry of MOG into cells leads to sufficiently high intracellular concentrations of NOG to inhibit glutamate dehydrogenase and other glutamine metabolism enzymes, suppress mitochondrial respiration, decrease TCA-cycle flux from glutamine, and reduce ATP production, causing cytotoxicity in an MCT2-dependent manner.\",\n      \"method\": \"LC-MS metabolomics, MCT2 KD/KO, transport assays, mitochondrial respiration assays, cell viability assays\",\n      \"journal\": \"Nature chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — transport mechanism linked to metabolic outcome via multiple orthogonal methods including metabolomics and genetic loss-of-function; single lab\",\n      \"pmids\": [\"30297875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MOG analogues that maintain MCT2-dependent cell entry but do not inhibit glutaminolysis or cause cytotoxicity were identified, functionally mapping the MCT2 pharmacophore. These compounds can still inhibit PHDs, allowing uncoupling of glutaminolysis from PHD activity and demonstrating that MCT2 dictates the mode of action of NOG by controlling its intracellular concentration.\",\n      \"method\": \"Structure-activity relationship with MOG analogues, cell viability assays, metabolic flux assays, MCT2-expressing cell lines\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacophore mapping with multiple analogues and functional readouts; single lab\",\n      \"pmids\": [\"36028752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Notch/RBP-J signaling represses MCT2 transcription via its downstream effector Hes1, reducing intracellular lactate levels in myeloid cells. Reduced MCT2-mediated lactate import blunts granulocytic MDSC differentiation and promotes TAM maturation. Lactate (transported via MCT2) was identified to interact with and stabilize c-Jun protein against FBW7 ubiquitin-ligase-mediated degradation, using LC-MS and CRISPR-Cas9 gene disruption.\",\n      \"method\": \"Chromatin immunoprecipitation (Hes1 at MCT2 locus), LC-MS (lactate-c-Jun interaction), CRISPR-Cas9 KO, flow cytometry, Western blot\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods including ChIP, LC-MS, and CRISPR in single lab; pathway placement with defined molecular mechanism\",\n      \"pmids\": [\"35263597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MCT2 regulation of GluR2 AMPA receptor subcellular distribution was demonstrated: co-expression of MCT2 with GluR2-Venus in Neuro2A cells and cortical neurons caused GluR2 to redistribute into perinuclear and dendritic clusters following MCT2 distribution. MCT2 co-expression reduced both cell-surface and total GluR2 protein levels. MCT2 partially co-localized with Rab8 in dendrites, suggesting involvement in AMPA receptor membrane trafficking.\",\n      \"method\": \"Fluorescence microscopy with mStrawberry-MCT2 and Venus-GluR2 co-transfection, cell-surface biotinylation, Western blot\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct visualization of MCT2 influence on GluR2 trafficking with multiple readouts; single lab\",\n      \"pmids\": [\"19457092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Neuronal MCT2 knockdown (~25%) in rat somatosensory cortex using lentiviral shRNA abrogated the activity-dependent increase in lactate content observed during whisker stimulation (measured by HRMAS 1H-NMR and in vivo 1H-NMR). MCT2 KD also attenuated TCA cycle velocity increase upon activation and abolished the BOLD fMRI response to whisker stimulation. 13C-labeling confirmed that elevated lactate during activation originates from newly synthesized glucose-derived lactate.\",\n      \"method\": \"Lentiviral shRNA KD, HRMAS 1H-NMR spectroscopy, 13C-NMR with [1-13C]glucose infusion, in vivo 1H-NMR, BOLD fMRI\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic KD with multiple independent readouts (NMR, 13C-labeling, fMRI); single lab, orthogonal methods\",\n      \"pmids\": [\"28388627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MCT2 localizes predominantly to peroxisomes in prostate cancer (PCa) cells, interacting with the peroxisomal membrane protein Pex19 to exploit the peroxisomal import machinery. This peroxisomal localization correlates with increased peroxisomal β-oxidation activity and is associated with malignant transformation.\",\n      \"method\": \"Immunofluorescence co-localization with peroxisomal markers, co-immunoprecipitation with Pex19, Western blot, immunohistochemistry\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — co-IP of MCT2-Pex19 interaction with co-localization and functional correlation; single lab\",\n      \"pmids\": [\"25639644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Peroxisomal localization of MCT2 is required for PCa cell proliferation: MCT2 knock-down reduced PCa cell growth, and re-expression of MCT2 variants unable to localize to peroxisomes did not rescue proliferation, whereas peroxisome-targeted MCT2 did.\",\n      \"method\": \"siRNA knockdown, rescue with localization-variant constructs, proliferation assays\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with localization-specific rescue experiment; single lab\",\n      \"pmids\": [\"33121137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Epigenetic demethylation of an internal SLC16A7/MCT2 promoter is a recurrent event in prostate cancer, driving expression of isoforms differing in 5'-UTR translational control motifs, contributing to MCT2 protein overexpression. Androgen receptor (AR) and ERG transcription factors bind at the SLC16A7 locus. MCT2 knockdown attenuated PCa cell growth.\",\n      \"method\": \"Bisulfite sequencing (methylation), integrative transcriptomic/epigenomic analysis, ChIP (AR/ERG), siRNA knockdown, cell proliferation assay\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms TF binding at locus, epigenetic mechanism supported by methylation data and isoform characterization; single lab\",\n      \"pmids\": [\"26035357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"MCT2 expression in spermatid tails is developmentally regulated, appearing at postnatal day 18 in elongating spermatids. MCT2 mRNA levels in testis are negatively regulated by FSH and testosterone (both reducing MCT2 mRNA in a dose-dependent manner in isolated seminiferous tubules), and also by TNF-α and TGF-β. Hypophysectomy caused an 8-fold increase in testicular MCT2 mRNA, reversed by FSH or LH administration.\",\n      \"method\": \"Northern blot, Western blot, immunoelectron microscopy, in vitro seminiferous tubule incubation with hormones, hypophysectomy model\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo hormonal manipulation plus in vitro dose-response; multiple methods; single lab\",\n      \"pmids\": [\"12773420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In preimplantation mouse embryos, SLC16A7 (MCT2) protein localizes to apical cortical regions and vesicular/peroxisomal compartments (partially co-localizing with peroxisomal catalase), distinct from plasma membrane localization of MCT4. SLC16A7 expression is upregulated in the absence of glucose, in contrast to MCT1 and MCT4 which require glucose, suggesting a unique role in peroxisomal redox regulation.\",\n      \"method\": \"Immunofluorescence localization, co-localization with peroxisomal catalase, Western blot, mRNA analysis under varying glucose conditions\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — localization by immunofluorescence with functional context from glucose deprivation experiments; single lab\",\n      \"pmids\": [\"18385447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BDNF injection into mouse hippocampal CA1 area enhanced MCT2 protein expression in vivo (confirmed by immunohistochemistry and immunoblot), co-occurring with upregulation of postsynaptic plasticity proteins PSD95 and GluR2 but not glial MCT1/MCT4, synaptic vesicle proteins, or αCaMKII. This places MCT2 upregulation in the context of BDNF-mediated synaptic plasticity.\",\n      \"method\": \"Intrahippocampal BDNF injection, immunohistochemistry, Western blot\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vivo demonstration of MCT2 upregulation by BDNF with selective protein panel; single lab, single method set\",\n      \"pmids\": [\"21736920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"AAV2-mediated overexpression of MCT2 in retinal ganglion cells (RGCs) of two glaucoma models preserved RGC density, axon number, and function (pattern ERG), reduced energy imbalance, and increased mitochondrial function (cytochrome c oxidase and succinate dehydrogenase activity). Conditional reduction of MCT2 in RGCs via AAV2-Cre in MCT2fl/+ mice caused significant decline in ATP production and visual evoked potential.\",\n      \"method\": \"AAV2-GFP-MCT2 intraocular injection, AAV2-Cre conditional KO, pattern ERG, RGC density quantification, enzyme activity assays (COX, SDH), ATP measurement\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus overexpression rescue in two disease models with multiple functional readouts; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"32422282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Deletion of MCT2 specifically in oligodendrocytes did not affect oligodendrocyte survival but resulted in downregulation of lipid synthesis-associated enzymes and failure of myelin maintenance. Concomitant axonal upregulation of lactate dehydrogenase A and axonal damage were observed. Ketogenic diet alleviated the axonal damage phenotype. MCT2 is expressed by myelinating oligodendrocytes in both mice and humans and is downregulated in progressive multiple sclerosis.\",\n      \"method\": \"Conditional KO in oligodendrocytes, immunohistochemistry, enzyme expression analysis, ketogenic diet intervention, human MS tissue analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific conditional KO with defined myelin and axonal phenotype; preprint, not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"AAV-mediated expression of MCT2 in retinal pigment epithelium (RPE) cells promoted cone survival and function in rat and mouse retinitis pigmentosa models. FLIM biosensors showed changes in lactate and glucose levels within MCT2-expressing RPE, suggesting MCT2 in RPE promotes lactate uptake from blood, alters RPE metabolism, and increases glucose availability to cones.\",\n      \"method\": \"AAV gene delivery to RPE, ERG and visual function testing, fluorescence lifetime imaging (FLIM) biosensors for lactate and glucose in vivo\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gene delivery with functional rescue and direct metabolite imaging; single lab\",\n      \"pmids\": [\"40178895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MCT2 knockdown in arcuate nucleus neurons of female rats (via AAV-shRNA) significantly increased food intake and body weight after fasting/refeeding, demonstrating that neuronal MCT2-mediated lactate transport in hypothalamic arcuate nucleus is required for normal satiety signaling. MCT2 KD also led to compensatory inhibition of MCT1, suggesting glial adaptation to increased parenchymal lactate.\",\n      \"method\": \"AAV-shRNA knockdown in arcuate nucleus, real-time PCR, Western blot, immunohistochemistry, feeding behavior analysis (macro/microstructure)\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — region-specific neuronal KD with defined behavioral phenotype and molecular compensation; single lab\",\n      \"pmids\": [\"40032881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Lactate transport via neuronal MCT2 is not required for sustained synchronized synaptic transmission (gamma oscillations or sharp wave-ripples) in hippocampal slices supplied with glucose. MCT1/2 blockade by AR-C155858 did not affect gamma oscillation properties when glucose was the energy supply, but fully suppressed oscillations when lactate was the sole substrate. Intracellular lactate accumulation in neurons upon MCT1/2 blockade was confirmed by FRET sensor imaging.\",\n      \"method\": \"Local field potential recordings, pharmacological MCT1/2 blockade (AR-C155858), UPLC-MS lactate measurement, FRET (Laconic sensor) imaging in neuron-astrocyte cultures\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple electrophysiology and metabolic readouts with pharmacological MCT blockade; negative finding (not required for glucose-supported oscillations) is mechanistically informative\",\n      \"pmids\": [\"41048117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"β-catenin directly binds to and transcriptionally activates the MCT2 promoter (confirmed by ChIP-qPCR with JASPAR motif prediction). β-catenin overexpression markedly increased MCT2 mRNA and protein. The β-catenin/c-Myc/MCT2 signaling axis regulates mitochondrial energy metabolism; gastrodin stabilizes β-catenin protein (confirmed by DARTS and CETSA), increasing MCT2 expression and pyruvate/ATP levels in AD models.\",\n      \"method\": \"ChIP-qPCR (β-catenin at MCT2 promoter), lentiviral β-catenin overexpression, Western blot, qPCR, DARTS, CETSA, ATP/pyruvate assays\",\n      \"journal\": \"Journal of ethnopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms direct transcriptional regulation; multiple orthogonal methods for pathway; single lab\",\n      \"pmids\": [\"40915373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Neuronal MCT2 is required for WS (whisker stimulation)-induced angiogenesis in neonatal mouse neocortex. MCT2 facilitates L-lactate influx into cortex, promoting lactate uptake by neurons and astrocytes, which activates HIF1α and VEGFa expression in astrocytes, driving angiogenesis. Neuronal MCT2 loss-of-function abolished these angiogenic and metabolic responses.\",\n      \"method\": \"RNA-seq, RNA-scope spatial transcriptomics, genetic loss-of-function, lactate measurements, immunofluorescence for VEGFa/HIF1α, vascular density quantification\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic LOF with multiple molecular readouts placing MCT2 in HIF1α/VEGF pathway; single lab\",\n      \"pmids\": [\"41046267\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC16A7/MCT2 is a high-affinity, proton-coupled monocarboxylate transporter (preferring pyruvate, lactate, and ketone bodies) that requires an ancillary protein—embigin (gp70) or, in some cell types, neuroplastins or basigin—for plasma membrane expression and activity; in neurons it localizes to postsynaptic densities where it co-traffics with AMPA receptor GluR2/3 subunits under control of the PI3K–Akt–mTOR–S6K translational pathway, while in prostate cancer cells it localizes to peroxisomes via Pex19 to support β-oxidation, and in oligodendrocytes it maintains myelin integrity; its transport activity can be augmented non-catalytically by extracellular carbonic anhydrase IV and inhibited by AR-C155858 binding to an intracellular site on TMs 7–10.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SLC16A7/MCT2 is a high-affinity, proton-coupled monocarboxylate transporter that moves pyruvate, lactate, and ketone bodies across membranes to support cellular energy metabolism [#0, #1, #2]. It distinguishes itself from other MCTs by its high substrate affinity (lactate Km ~0.74 mM; pyruvate Km ~25 µM) and by its insensitivity to organomercurial thiol reagents [#1, #2], a property explained by its preferential association with the ancillary protein embigin (gp70) rather than basigin/CD147 for plasma-membrane expression [#3]; neuroplastins serve this chaperone role in neural tissue, and basigin substitutes in spermatozoa, indicating cell-type-specific ancillary partnerships [#7, #14]. The ancillary protein modulates inhibitor sensitivity and surface delivery, while the transmembrane domains (TM7–12) set substrate affinity; the small-molecule inhibitor AR-C155858 binds an intracellular site formed by TMs 7–10, and extracellular carbonic anhydrase IV non-catalytically augments transport when embigin is present [#4, #5, #6]. In neurons, MCT2 is a postsynaptic density protein at glutamatergic synapses that co-distributes and co-traffics with AMPA receptor GluR2/3 subunits and PICK1, with surface delivery tied to neuronal lactate uptake and its protein levels controlled translationally through the PI3K–Akt–mTOR–S6K pathway downstream of insulin/IGF-1 and noradrenaline [#8, #9, #10, #11, #12, #18]. Neuronal MCT2-mediated lactate transport is required for activity-dependent metabolic and hemodynamic responses, angiogenesis, hypothalamic satiety signaling, and is neuroprotective in retinal and myelin contexts [#19, #29, #32, #26, #27]. In prostate cancer, MCT2 is redirected to peroxisomes via interaction with Pex19, where its peroxisomal localization supports β-oxidation and is required for proliferation, and its overexpression is driven by demethylation of an internal SLC16A7 promoter [#20, #21, #22]. MCT2 also governs the intracellular delivery and consequent activity of the small-molecule methyloxalylglycine, dictating its metabolic and cytotoxic mode of action [#15, #16]. No Mendelian disease link is established in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing the core identity of MCT2 required showing it is a proton-coupled monocarboxylate transporter, which defined its basic transport function and substrate selectivity.\",\n      \"evidence\": \"Heterologous expression in Sf9 insect cells and Xenopus oocytes with radiolabeled transport and pharmacological inhibition; cDNA cloning and FISH mapping to 12q13\",\n      \"pmids\": [\"7829520\", \"10417314\", \"9786900\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of the transporter resolved\", \"Stoichiometry of H+/monocarboxylate coupling not fully defined in these studies\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Quantitative kinetics established MCT2 as a high-affinity transporter (~10-fold higher affinity than MCT1) with a broad ketone-body/branched-keto-acid substrate range, explaining its niche in tissues requiring efficient low-substrate uptake.\",\n      \"evidence\": \"Xenopus oocyte radiolabeled transport assays with multiple substrates and inhibition kinetics\",\n      \"pmids\": [\"10417314\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-level relevance of each substrate not addressed\", \"Does not distinguish import vs export directionality in vivo\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identifying embigin rather than basigin as the obligate ancillary protein answered how MCT2 reaches the plasma membrane and mechanistically explained its distinct pharmacology (pCMBS insensitivity).\",\n      \"evidence\": \"Co-immunoprecipitation, FRET with CFP/YFP-tagged proteins, and site-directed mutagenesis of CD147\",\n      \"pmids\": [\"15917240\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of MCT2-embigin complex not defined\", \"Did not test whether embigin is universally required across all tissues\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Mapping the AR-C155858 binding site and showing the ancillary protein modulates inhibitor sensitivity defined which protein domains govern transport versus drug response, separating substrate affinity (TM domains) from inhibitor sensitivity (ancillary-dependent).\",\n      \"evidence\": \"Xenopus oocyte expression with chimeric/truncation constructs, microinjection, ancillary protein swaps, and inhibitor titrations\",\n      \"pmids\": [\"19929853\", \"20695846\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-crystal structure of inhibitor bound\", \"Conformational mechanism of ancillary modulation unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that extracellular carbonic anhydrase IV augments MCT2 transport non-catalytically revealed a regulatory partner that boosts flux independent of pH-buffering enzymatic activity.\",\n      \"evidence\": \"Xenopus oocyte co-expression with catalytically inactive CAIV mutants and pharmacological inhibition of CA activity\",\n      \"pmids\": [\"21680735\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context of CAIV-MCT2 interaction not established in native tissue\", \"Molecular interaction surface between CAIV and the MCT2-embigin complex undefined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identifying neuroplastins as MCT2 ancillary proteins explained how MCT2 achieves surface expression in neural tissue where embigin distribution may be limited.\",\n      \"evidence\": \"COS-7 co-transfection, Xenopus oocyte antisense knockdown, immunocytochemistry, and lactate transport assays\",\n      \"pmids\": [\"24260123\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of neuroplastin vs embigin in individual neuron types not quantified\", \"Whether neuroplastin alters inhibitor sensitivity not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defining MCT2 as a postsynaptic density protein that physically and functionally co-traffics with AMPA receptor GluR2/3 and PICK1 connected lactate transport to activity-dependent synaptic delivery and metabolic support of excitatory neurons.\",\n      \"evidence\": \"Immunogold EM, reciprocal co-IP, surface biotinylation, parallel trafficking experiments, and fluorescent lactate flux assays\",\n      \"pmids\": [\"11291733\", \"15749979\", \"19453627\", \"19457092\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MCT2 trafficking is causally required for AMPA receptor trafficking versus co-regulated unresolved\", \"Functional consequence of vesicular MCT2 pool not directly measured\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showing MCT2 protein is upregulated translationally via PI3K-Akt-mTOR-S6K by noradrenaline, insulin, IGF-1, and BDNF established that neuronal MCT2 abundance is a tunable, signal-responsive node rather than transcriptionally fixed.\",\n      \"evidence\": \"Western blot with mRNA/protein dissociation, selective pathway inhibitors, and in vivo BDNF injection with immunohistochemistry\",\n      \"pmids\": [\"17394554\", \"18093179\", \"21736920\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No genetic rescue to confirm pathway specificity\", \"Direct mRNA targets/translational control elements not identified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Discovery of peroxisomal MCT2 localization via Pex19 in prostate cancer revealed an organelle-specific role distinct from plasma-membrane transport, linking MCT2 to β-oxidation and malignant proliferation.\",\n      \"evidence\": \"Co-localization with peroxisomal markers, co-IP with Pex19, localization-variant rescue of proliferation, bisulfite methylation analysis, and ChIP for AR/ERG\",\n      \"pmids\": [\"25639644\", \"33121137\", \"26035357\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Substrate transported by peroxisomal MCT2 not directly demonstrated\", \"Mechanism connecting peroxisomal transport to proliferation undefined\", \"Whether embigin/ancillary protein participates in peroxisomal targeting unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showing MCT2 controls cellular uptake of methyloxalylglycine and thereby dictates its metabolic mode of action established MCT2 as a determinant of small-molecule pharmacology and intracellular drug concentration.\",\n      \"evidence\": \"LC-MS metabolomics, MCT2 KD/KO, transport assays, respiration assays, and SAR with MOG analogues\",\n      \"pmids\": [\"30297875\", \"36028752\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality to other monocarboxylate-mimetic drugs not established\", \"Native physiological substrate competition with such drugs not quantified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating transcriptional control of MCT2 by Notch/Hes1 and β-catenin, and lactate-mediated c-Jun stabilization, placed MCT2 within signaling networks where lactate import acts as a metabolic and signaling input.\",\n      \"evidence\": \"ChIP for Hes1 and β-catenin at the MCT2 locus, LC-MS lactate-c-Jun interaction, CRISPR-Cas9 KO, and DARTS/CETSA\",\n      \"pmids\": [\"35263597\", \"40915373\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct lactate-c-Jun binding mode not structurally resolved\", \"Cell-type generality of β-catenin/c-Myc/MCT2 axis not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"In vivo neuronal MCT2 knockdown studies established that MCT2-mediated lactate transport is functionally required for activity-dependent metabolic responses, neurovascular coupling, angiogenesis, satiety signaling, and neuroprotection.\",\n      \"evidence\": \"Lentiviral/AAV shRNA and conditional KO with NMR/13C-labeling, fMRI, RNA-seq, feeding behavior, ERG, and enzyme/ATP assays across cortex, hypothalamus, retina, and oligodendrocytes\",\n      \"pmids\": [\"28388627\", \"32422282\", \"40032881\", \"41046267\", \"40178895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of MCT2 versus other MCTs in each tissue not fully isolated\", \"Whether transport per se or protein-protein scaffolding drives some phenotypes unresolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Cell-type-specific MCT2 deletion and pharmacological blockade refined when lactate transport is dispensable versus essential, showing it is required for myelin maintenance and lactate-only-fueled oscillations but not for glucose-supported synaptic transmission.\",\n      \"evidence\": \"Oligodendrocyte conditional KO with ketogenic-diet rescue and human MS tissue analysis; LFP recordings with AR-C155858 and FRET lactate sensors\",\n      \"pmids\": [\"41048117\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Oligodendrocyte KO finding is from a preprint not yet peer-reviewed\", \"Mechanism linking MCT2 loss to lipid-synthesis enzyme downregulation undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MCT2 is sorted between plasma membrane, peroxisomes, and mitochondria in different cell types, and what governs the choice of ancillary partner, remains the central unresolved question.\",\n      \"evidence\": \"No reconciling study in the available corpus addresses the targeting determinants across organelles and tissues\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural basis for substrate selectivity or organelle targeting\", \"Mechanism dictating embigin vs neuroplastin vs basigin choice unknown\", \"Direct demonstration of peroxisomal/mitochondrial transport substrate lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 1, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 8, 9, 10]},\n      {\"term_id\": \"GO:0005777\", \"supporting_discovery_ids\": [20, 21, 24]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [9, 18]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 15, 19]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [8, 9, 10, 19]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"EMB\", \"NPTN\", \"BSG\", \"CA4\", \"GRIA2\", \"PICK1\", \"PEX19\", \"AQP9\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}